Working... Menu

To Demonstrate Equivalence in Analgesic Efficacy & Bowel Function Between OXN PR Higher Dose & Lower Dose Tablet Strengths in Subjects With Non-cancer or Cancer Pain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02321397
Recruitment Status : Completed
First Posted : December 22, 2014
Last Update Posted : November 4, 2016
Information provided by (Responsible Party):
Mundipharma Research GmbH & Co KG

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2016
  Actual Study Completion Date : September 2016